Allmed Solutions Ltd - Asset Resilience Ratio

Latest as of December 2025: 80.03%

Allmed Solutions Ltd (ALMD) has an Asset Resilience Ratio of 80.03% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Allmed Solutions Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

ILA25.25 Million
≈ $67.68K USD Cash + Short-term Investments

Total Assets

ILA31.54 Million
≈ $84.57K USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2008–2025)

This chart shows how Allmed Solutions Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Allmed Solutions Ltd (ALMD) total assets.

Liquid Assets Composition Over Time

This chart breaks down Allmed Solutions Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Allmed Solutions Ltd (ALMD) financial obligations for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ILA0.00 0%
Short-term Investments ILA25.25 Million 80.03%
Total Liquid Assets ILA25.25 Million 80.03%

Asset Resilience Insights

  • Very High Liquidity: Allmed Solutions Ltd maintains exceptional liquid asset reserves at 80.03% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

Allmed Solutions Ltd Industry Peers by Asset Resilience Ratio

Compare Allmed Solutions Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
TransMedics Group Inc
NASDAQ:TMDX
Medical Devices 0.00%
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
Medical Devices 0.84%
Novocure Ltd
NASDAQ:NVCR
Medical Devices 43.72%
Shenzhen New Industries Biomedical
SHE:300832
Medical Devices 9.95%
Jafron Biomedical Co Ltd
SHE:300529
Medical Devices 34.37%
Hangzhou AGS MedTech Co. Ltd. A
SHG:688581
Medical Devices 18.80%
Nanjing Vishee Medical Technology Co Ltd
SHG:688580
Medical Devices 10.74%
Nanjing Medlander Medical Technology Co. Ltd. A
SHG:688273
Medical Devices 34.29%

Annual Asset Resilience Ratio for Allmed Solutions Ltd (2008–2025)

The table below shows the annual Asset Resilience Ratio data for Allmed Solutions Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 80.03% ILA25.25 Million
≈ $67.68K
ILA31.54 Million
≈ $84.57K
-7.63pp
2024-12-31 87.66% ILA39.27 Million
≈ $105.27K
ILA44.79 Million
≈ $120.09K
+2.44pp
2023-12-31 85.22% ILA50.43 Million
≈ $135.19K
ILA59.17 Million
≈ $158.63K
+77.27pp
2019-12-31 7.96% ILA5.35 Million
≈ $14.34K
ILA67.20 Million
≈ $180.17K
-12.94pp
2018-12-31 20.89% ILA9.00 Million
≈ $24.14K
ILA43.09 Million
≈ $115.52K
-8.06pp
2017-12-31 28.95% ILA15.01 Million
≈ $40.24K
ILA51.85 Million
≈ $139.02K
+7.87pp
2016-12-31 21.08% ILA11.01 Million
≈ $29.51K
ILA52.22 Million
≈ $140.00K
-15.81pp
2015-12-31 36.88% ILA21.01 Million
≈ $56.32K
ILA56.95 Million
≈ $152.69K
+28.78pp
2012-12-31 8.10% ILA6.52 Million
≈ $17.49K
ILA80.52 Million
≈ $215.88K
+7.76pp
2011-12-31 0.34% ILA270.00K
≈ $723.86
ILA79.55 Million
≈ $213.28K
-20.63pp
2008-12-31 20.96% ILA3.25 Million
≈ $8.70K
ILA15.48 Million
≈ $41.51K
--
pp = percentage points

About Allmed Solutions Ltd

TA:ALMD Israel Medical Devices
Market Cap
$7.99 Million
ILA2.98 Billion ILA
Market Cap Rank
#27700 Global
#392 in Israel
Share Price
ILA31.00
Change (1 day)
-3.13%
52-Week Range
ILA26.60 - ILA40.50
All Time High
ILA186.00
About

Allmed Solutions Ltd develops, manufactures, and markets minimally invasive products in various medical disciplines in Israel and internationally. The company offers drugs, biological products, and medical devices; and ProCatid system, a distal embolic protection system comprised of an independent filter unit that can be delivered, locked, and deployed on any commercially marketed guide wires. It… Read more